17. When managing NSGCTs, PM is indicated for select patients with limited number of lung
abnormalities after first-line or second-line platin-based chemotherapy suspected of …

Context The benefit of surgical metastasectomy (SM) for patients with metastatic renal cell
carcinoma (mRCC) remains controversial because of the lack of high-level evidence on the …

Purpose Stereotactic ablative radiotherapy (SAbR) is a promising alternative for selected
patients with renal cell carcinoma (RCC) with oligometastasis. The objective of this study …

Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …

The past decade has seen a rapid proliferation in the number and types of systemic
therapies available for renal cell carcinoma. However, surgery remains an integral …

Simple Summary Methods of treatment should be carefully considered. Systemic therapy is
recommended for patients susceptible to this method, as it will allow them to avoid surgery …

Background Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-
year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have …

Background Renal cell carcinoma (RCC) is traditionally considered to be radioresistant.
Radiotherapy response rates are believed to improve with hypofractionated, high dose …

Despite the rapid elaboration of multiple, novel systemic agents introduced for metastatic
renal cell carcinoma (mRCC) in recent years, a durable complete response remains elusive …

Abstract Background and Objectives Metastatic renal cell carcinoma to the pancreas (PM‐
RCC) is infrequent; we sought to describe the characteristics of PM‐RCC and analyze the …